Result Filters
HIF-1: a target for cancer, ischemia and inflammation--too good to be true?
- 1
- Developmental Therapeutics Program, Science Applications International Corporation, Frederick, Inc, National Cancer Institute, Frederick, Maryland 21702, USA. melillog@ncifcrf.gov
Publication types
MeSH terms
Substances
Grant support